Literature DB >> 9663573

A comparison between TNM and TANIS stage grouping for predicting prognosis of oral and oropharyngeal cancer.

F Carinci1, S Pelucchi, A Farina, C Calearo.   

Abstract

PURPOSE: The 1987 TNM classification system modified some T and N definition but it did not change stage grouping. Consequently it has not improved the prognostic validity of the advanced stage groups. In 1993, a new stage grouping was purposed, TANIS, that seems to have a higher correlation with survival. In this report, the TNM classification and TANIS system were compared to evaluate this prognostic ability. PATIENTS AND METHODS: Data from 164 patients affected by primary cancers of oropharynx or oral cavity were analyzed by means of Kaplan-Meier and Cox regression analysis.
RESULTS: The crude survival rate at 5 years was 43.9%. Both systems showed a significant correlation with the survival rate by means of Cox regression analysis. TANIS subcategories were correlated to the mortality rate in the stage IV patients. TANIS resulted a better predictor of mortality when compared with TNM.
CONCLUSION: The TANIS system was able to separate the TNM stage IV patients into prognostic groups, yielding more information with respect to TNM for such a category of patients. When a comparison between TNM and TANIS was performed, it was observed that TANIS had a higher correlation with survival rate, whereas TNM did not add any information in defining the survival function.

Entities:  

Mesh:

Year:  1998        PMID: 9663573     DOI: 10.1016/s0278-2391(98)90007-6

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  2 in total

1.  Analysis of Survival Rates Following Primary Surgery of 178 Consecutive Patients with Oral Cancer in a Large District General Hospital.

Authors:  Panagiotis Stathopoulos; William P Smith
Journal:  J Maxillofac Oral Surg       Date:  2016-07-08

2.  The development and validation of oral cancer staging using administrative health data.

Authors:  Chang Li-Ting; Chen Chung-Ho; Yang Yi-Hsin; Ho Pei-Shan
Journal:  BMC Cancer       Date:  2014-05-29       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.